https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-revokes-emergency-use-authorization-monoclonal-antibody-bamlanivimab
Originally published by: fda.gov
Author: staff
Date: 4/16/2021
Categories: Integrative Therapies,Treatment
0 Comments